MR evaluation of stent patency: in vitro test of 22 metallic stents and the possibility of determining their patency by MR angiography

Detecting stent geometry changes after venous recanalization using duplex ultrasound

Background

Patients with post-thrombotic syndrome due to chronic venous obstruction and resistant to conservative management can benefit from endovenous revascularization. The current study investigated the usefulness of duplex ultrasound in monitoring the stent changes over the time.

Method

All duplex ultrasound images of treated patients were reviewed retrospectively. The stent diameter and area during the follow-up visits have been analyzed.

Result

A total of 210 stents were placed in 137 limbs. Duplex ultrasound findings showed a decrease in area of stent in all patients (mean: 0.69 cm2). Reduction of stent area over the time was a predictor of stent patency (odds ratio: 0.910; confidence interval: 0.832–0.997).

Conclusion

Duplex ultrasound has sufficient accuracy in detection of stent changes and its patency. There is a discrepancy between diameter of the stent lumen in vitro and after deployment in all patients. Stent occlusion is related to reduction of stent lumen over the time rather than the percent of the stenosis.

Neurosonology and noninvasive imaging of the carotid arteries

In this chapter, we review imaging of the extracranial carotid arteries and the indications for noninvasive carotid artery evaluation, measuring the degree of arterial stenosis and plaque morphology. We also analyze the types of noninvasive imaging, including carotid duplex ultrasound, transcranial Doppler, magnetic resonance angiography, and computer tomography angiography. We look at each of these modalities, briefly discussing techniques, benefits, limitations, and sources of error. Furthermore, we discuss the apparent accuracy and the need for multimodality imaging. Finally, an imaging algorithm for the evaluation of the extracranial carotid arteries is proposed, which is in routine use at our hospital.

Current issues in coronary stent technology

Coronary artery stents have become the medical device of choice for the treatment of coronary artery disease. Since their introduction in 1987, significant advances in stent technology have taken place. A major objective of these developments was the reduction of in-stent restenosis, the formation of neointimal tissue inside the stent triggered by vessel injury and the inflammatory response, which results in renarrowing of the coronary artery. Improvements in strut configuration, thickness, and materials have enhanced deliverability and reduced vessel damage. Currently available drug-eluting stents release drugs that reduce neointimal formation through the arrest of cell proliferation. Drug-eluting stents have significantly reduced rates of in-stent restenosis. However, concerns have been raised with respect to their long-term safety, particularly in relation to the occurrence of late thrombosis. The post-procedural monitoring of stent-related complications is also of interest, including the relative suitability of invasive techniques such as angiography and intravascular ultrasound, and non-invasive techniques such as computed tomography and magnetic resonance imaging scanning. This paper reviews the current issues in stent technology.

Development of a new niobium-based alloy for vascular stent applications

This study was performed in order to develop a new stent material that would provide reduced MR image artifact compared to current stent materials. Alloy design rationale is initially presented and following this the development of a Nb-28 Ta-3.5 W-1.3 Zr alloy is described, including the manufacture of stent tubing. Tensile testing of this new alloy showed that it had approximately twice the yield strength of current Nb-1 Zr material with a 25% higher elastic modulus. The new alloy was also confirmed to have suitably low magnetic susceptibility. Mechanical testing of demonstration coronary stents made from the new alloy were shown to have acceptable compression strength and elastic recoil performance. It is concluded that this new Nb-28 Ta-3.5 W-1.3 Zr alloy is a practical candidate stent material for both coronary applications and peripheral uses such as carotid or intracranial stenting, where reduced MR image artifact would be beneficial.

Delivery and assessment of endovascular stents to repair aortic coarctation using MR and X-ray imaging

PURPOSE

To investigate the utility of MR and X-ray imaging for characterizing aortic coarctation and flow, and guiding the endovascular catheter to place a stent to repair the coarctation.

MATERIALS AND METHODS

The descending aorta in eight dogs was looped with elastic band and tightened distal to the subclavian artery. Balanced fast field echo (bFFE) and velocity-encoded cine (VEC) MRI sequences were used for device tracking and measuring aortic flow. A T1-weighted fast-field echo sequence (T1-FFE) was used to visualize the coarctation and roadmap the aorta. Nitinol stents were guided by a nitinol guidewire and placed under MR guidance.

RESULTS

Aortic coarctation was visible on MR and X-ray imaging. The procedure success rate was 88%. VEC MRI measured the changes in aortic flow (baseline = 1.3 +/- 0.2, coarctation = 0.2 +/- 0.02, and stent placement = 0.8 +/- 0.1 liters/minute). A significant reduction in iliac blood pressure was measured after coarctation, but it was reversed by stent placement. The stent lumen was visible on X-ray fluoroscopy, but not on MRI.

CONCLUSION

Stent deployment to repair aortic coarctation is feasible under MR guidance. The combined use of MR and X-ray imaging is effective for anatomic and functional evaluation of aortic coarctation dilation, which may be crucial for optimal therapy.

In vitroevaluation of stent patency and in-stent stenoses in 10 metallic stents using MR angiography

In vitro study to investigate the suitability of contrast enhanced magnetic resonance angiography (CEMRA) for determination of stent patency and grading of in-stent stenoses in 10 metallic stents. The Acculink carotid, DynaLink, Easy Wallstent, JostentSelfX XF, Luminexx, Omnilink, sinus-SuperFlex, SMART, Symphony and ZA stent were separately placed in a vascular phantom. Dedicated stenoses inside the stents generated a concentric lumen narrowing of 50%. CEMRA was performed for each stent. Signal loss inside the stents and artificial lumen narrowing were assessed objectively using the evaluation software of the MR imager. Moreover, three blinded observers determined visibility of stent patency and in-stent stenoses subjectively on a 3-point scale and graded in-stent stenoses. Loss of signal intensity within the stent lumen ranged between 90% (Wallstent) and 5% (ZA), artificial lumen narrowing between 56% (Symphony) and 22% (ZA). For the Symphony and Wallstent, visibility of patency and in-stent stenoses was impaired and the observers' grading exaggerated the degree of stenoses (by 23% and 33%, respectively). For the remainder of stents, patency and stenoses were visible and stenoses were graded accurately (less than 10% discrepancy from reference standard). In this in vitro study, eight of 10 stents presented with MRI characteristics which enabled determination of stent patency and accurate grading of clinically relevant in-stent stenoses.

Finite volume analysis of temperature effects induced by active MRI implants: 2. Defects on active MRI implants causing hot spots

BACKGROUND

Active magnetic resonance imaging implants, for example stents, stent grafts or vena cava filters, are constructed as wireless inductively coupled transmit and receive coils. They are built as a resonator tuned to the Larmor frequency of a magnetic resonance system. The resonator can be added to or incorporated within the implant. This technology can counteract the shielding caused by eddy currents inside the metallic implant structure. This may allow getting diagnostic information of the implant lumen (in stent stenosis or thrombosis for example). The electro magnetic rf-pulses during magnetic resonance imaging induce a current in the circuit path of the resonator. A by material fatigue provoked partial rupture of the circuit path or a broken wire with touching surfaces can set up a relatively high resistance on a very short distance, which may behave as a point-like power source, a hot spot, inside the body part the resonator is implanted to. This local power loss inside a small volume can reach (1/4) of the total power loss of the intact resonating circuit, which itself is proportional to the product of the resonator volume and the quality factor and depends as well from the orientation of the resonator with respect to the main magnetic field and the imaging sequence the resonator is exposed to.

METHODS

First an analytical solution of a hot spot for thermal equilibrium is described. This analytical solution with a definite hot spot power loss represents the worst case scenario for thermal equilibrium inside a homogeneous medium without cooling effects. Starting with this worst case assumptions additional conditions are considered in a numerical simulation, which are more realistic and may make the results less critical. The analytical solution as well as the numerical simulations use the experimental experience of the maximum hot spot power loss of implanted resonators with a definite volume during magnetic resonance imaging investigations. The finite volume analysis calculates the time developing temperature maps for the model of a broken linear metallic wire embedded in tissue. Half of the total hot spot power loss is assumed to diffuse into both wire parts at the location of a defect. The energy is distributed from there by heat conduction. Additionally the effect of blood perfusion and blood flow is respected in some simulations because the simultaneous appearance of all worst case conditions, especially the absence of blood perfusion and blood flow near the hot spot, is very unlikely for vessel implants.

RESULTS

The analytical solution as worst case scenario as well as the finite volume analysis for near worst case situations show not negligible volumes with critical temperature increases for part of the modeled hot spot situations. MR investigations with a high rf-pulse density lasting below a minute can establish volumes of several cubic millimeters with temperature increases high enough to start cell destruction. Longer exposure times can involve volumes larger than 100 mm3. Even temperature increases in the range of thermal ablation are reached for substantial volumes. MR sequence exposure time and hot spot power loss are the primary factors influencing the volume with critical temperature increases. Wire radius, wire material as well as the physiological parameters blood perfusion and blood flow inside larger vessels reduce the volume with critical temperature increases, but do not exclude a volume with critical tissue heating for resonators with a large product of resonator volume and quality factor.

CONCLUSION

The worst case scenario assumes thermal equilibrium for a hot spot embedded in homogeneous tissue without any cooling due to blood perfusion or flow. The finite volume analysis can calculate the results for near and not close to worst case conditions. For both cases a substantial volume can reach a critical temperature increase in a short time. The analytical solution, as absolute worst case, points out that resonators with a small product of inductance volume and quality factor (Q V(ind) < 2 cm3) are definitely save. Stents for coronary vessels or resonators used as tracking devices for interventional procedures therefore have no risk of high temperature increases. The finite volume analysis shows for sure that also conditions not close to the worst case reach physiologically critical temperature increases for implants with a large product of inductance volume and quality factor (Q V(ind) > 10 cm3). Such resonators exclude patients from exactly the MRI investigation these devices are made for.

Successful nitinol stent implantation in a large coronary aneurysm: post-interventional patency assessment by magnetic resonance imaging

Nitinol stents are thought to exhibit reduced occurrence of artifacts and may be suitable for magnetic resonance imaging (MRI) evaluation of stent localization and in-stent patency even in coronary-sized stent grafts. A 54-year-old male patient presented with a large coronary post-stenotic aneurysm of the right coronary artery (RCA) beside significant stenoses of the left circumflex coronary artery (LCX) and the left anterior descending coronary artery (LAD) with aneurysm formation. After implantation of stent grafts to the LAD and LCX, two polymermembrane-covered nitinol stent grafts were placed into the RCA. A control MR examination 7 days following the RCA intervention showed successful occlusion of the former aneurysm, no post-interventional endoleak, and bright signal within the stent indicating stent patency. Thus, coronary MRI after nitinol stent implantation in coronary aneurysms is feasible for post-interventional early imaging control at least as far as the exclusion of possible endoleaks is concerned.

3.0 T vs. 1.5 T MR angiography: In vitro comparison of intravascular stent artifacts

PURPOSE

To evaluate the signal characteristics of different iliac artery stents in MR angiography (MRA) at 3 T in comparison with 1.5 T.

MATERIALS AND METHODS

Sixteen iliac artery stents were implanted in plastic tubes filled with a solution of Gd-DTPA and imaged at 3 T and 1.5 T using a T1-weighted 3D spoiled gradient-echo sequence. Image analysis included a subjective assessment of artifact characteristics, signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) measurements in stented and unstented vessel parts, and quantitative measurements of total artifact size.

RESULTS

The pattern of stent artifacts inside the stents evidently did not differ at 3 T and 1.5 T. The average total size of the artifact areas surrounding the stents was significantly larger at 3 T (P < 0.03). However, within the stented part of the vessel phantom, the signal of the lumen and its contrast to modeled surrounding tissue was significantly higher at the higher field. The mean SNR of the lumen increased from 95.5 at 1.5 T to 127.3 at 3 T, and the CNR of the vessel increased from 70.3 to 93.

CONCLUSION

Assessment of the stent lumen in iliac artery stents in a phantom model is not compromised by imaging at 3 T compared to 1.5 T. The signal gain inside the stented part of the vessel lumen at higher field compensates for the higher degree of stent artifacts seen in stents made of steel or cobalt.

In Vivo Evaluation of Patency and In-Stent Stenoses After Implantation of Nitinol Stents in Iliac Arteries Using MR Angiography

OBJECTIVE

Our study was a prospective in vivo study to evaluate whether MR angiography is suitable for assessing stent patency and grading in-stent stenoses and to examine whether the accuracy of MR angiography changes with time after stent implantation.

SUBJECTS AND METHODS

In a prospective study, 34 iliac stenoses in 27 patients were treated by implantation of 35 nitinol stents. MR angiography was performed immediately after stent placement for 32 stents, and both digital subtraction angiography (DSA) and MR angiography were repeated at the 6-month follow-up for 23 stents. Three blinded observers assessed stent patency and the degree of in-stent stenoses on MR angiography and DSA (the standard of reference) images. The difference between the observers' grading of stenoses on DSA and on MR angiography was determined. Statistical analysis was performed using the Student's t test for paired samples.

RESULTS

Stent patency was assessed correctly for all stents and both sets of MR angiography images. Evaluation of DSA 1 images (obtained at end of implantation procedure) revealed that 96.9% of in-stent stenoses were less than 50%. On DSA 2 images (obtained at follow-up), 95.7% of in-stent stenoses were graded as less than 50%. The difference between grading of stenoses on DSA and MR angiography images was 15.0% +/- 16.0% (minimum, 0.0%; maximum, 63.3%) for DSA 1 versus MR angiography 1 (statistically significant, p = 0.037) and 9.8% +/- 13.5% (minimum, 0.0%; maximum, 63.3%) for MR angiography 2 versus DSA 2 (not statistically significant, p = 0.355).

CONCLUSION

Patency was correctly assessed for all stents on MR angiography. The quality of MR angiography regarding characterization of in-stent stenoses improved with time after stent placement. However, discrepancies of more than 60% between grading of lumen narrowing on DSA and MR angiography images occurred even at the 6-month follow-up. Thus, MR angiography is not yet a reliable technique for characterization of in-stent stenoses.

rf enhancement and shielding in MRI caused by conductive implants: dependence on electrical parameters for a tube model

Radio frequency (rf) eddy-currents induced in implants made of conductive material might cause significant image artifacts in magnetic resonance imaging (MRI) such as shielding of the lumen of vascular stents. rf alteration near metal parts was assessed theoretically in the approximation of alternating current electrodynamics: The implant was modeled as tube with diameter d(o), resistance R, and reactance Y, constituting the secondary winding of a transformer. The transmitter coil of the scanner acted as primary winding and generated the linearly polarized rf field B1,app. Tube axis was assumed parallel to B1,app. The results of the calculations were as follows: Ninety percent of the applied rf-field amplitude is reached in the lumen at a ratio chi=R/Y approximately 2. A rapid drop occurs with the reduction of chi, whereas a further increase of chi causes only a small effect. With chi approximately 1/d(o)(Y approximately d2o,R approximately d(o)), conditions for rf alteration clearly depend on the diameter of the tube. Inside tubes with smaller diameter, rf shielding is less pronounced. rf alteration increases in good approximation with the square root of the strength of the static field B0. The following experiments were carried out: Tubes of similar diameter (d(o) approximately 8 mm) made of material of different conductivity (Cu, Nitinol, carbon fiber reinforced plastic with three different fiber structures) were examined at B0=0.2 and 1.5 T in water phantoms. Tube axis was aligned perpendicular to B0 and spin-echo technique was applied. Local rf enhancement near the outer surface of the metal tubes was detected applying manual reduction of the transmitter amplitude. Shielding inside a carbon fiber tube with d(o) approximately 8 mm and inside a smaller tube with d(o)=3.3 mm was compared. Both tubes showed the same wall structure and thickness (d(w)=0.4 mm). All measurements confirmed the theoretical results. Consequences for the construction of vascular stents are discussed, as well as problems with image artifacts due to rf enhancement near solid conductive implants.

In Vivo Evaluation of the Carotid Wallstent on Three-dimensional Contrast Material–enhanced MR Angiography: Influence of Artifacts on the Visibility of Stent Lumina

PURPOSE

Contrast material-enhanced magnetic resonance (MR) angiography is increasingly used in postinterventional imaging after implantation of endovascular stents. The main limitations are stent-related artifacts compromising the visibility of the stent lumen. The aim of this in vivo study is the evaluation of contrast-enhanced MR angiography imaging characteristics of the carotid Wallstent.

MATERIALS AND METHODS

The carotid arteries of 29 patients were examined with contrast-enhanced MR angiography 3-6 days and/or 7-23 months after implantation of a carotid Wallstent into the internal carotid artery. Images were evaluated with regard to the diameter and signal intensity (SI) of the visible stent lumen. Digital subtraction angiography (DSA) was used as the standard of reference.

RESULTS

Stent-related artifacts on contrast-enhanced MR angiography caused an artificial lumen narrowing and a reduction of the SI within the stent. Artifacts were pronounced on imaging 3-6 days after stent implantation, but 68% of stents imaged 7-23 months after stent implantation presented with a significantly decreased artificial signal reduction and an improved visibility of the stent lumen.

CONCLUSIONS

The results of this study indicate that a reliable evaluation of the stent lumen is limited as a result of an artificial decrease of the SI inside the stent. However, in follow-up examinations 7-23 months after stent implantation, visibility of the stent lumen was improved and diagnostic reliability of contrast-enhanced MR angiography was markedly increased. A probable explanation for this phenomenon might be the formation of a neointimal layer covering the stent struts and thereby reducing stent-related artifacts.

Finite volume analysis of temperature effects induced by active MRI implants with cylindrical symmetry: 1. Properly working devices

Background

Active Magnetic Resonance Imaging implants are constructed as resonators tuned to the Larmor frequency of a magnetic resonance system with a specific field strength. The resonating circuit may be embedded into or added to the normal metallic implant structure. The resonators build inductively coupled wireless transmit and receive coils and can amplify the signal, normally decreased by eddy currents, inside metallic structures without affecting the rest of the spin ensemble. During magnetic resonance imaging the resonators generate heat, which is additional to the usual one described by the specific absorption rate. This induces temperature increases of the tissue around the circuit paths and inside the lumen of an active implant and may negatively influence patient safety.

Methods

This investigation provides an overview of the supplementary power absorbed by active implants with a cylindrical geometry, corresponding to vessel implants such as stents, stent grafts or vena cava filters. The knowledge of the overall absorbed power is used in a finite volume analysis to estimate temperature maps around different implant structures inside homogeneous tissue under worst-case assumptions. The "worst-case scenario" assumes thermal heat conduction without blood perfusion inside the tissue around the implant and mostly without any cooling due to blood flow inside vessels.

Results

The additional power loss of a resonator is proportional to the volume and the quality factor, as well as the field strength of the MRI system and the specific absorption rate of the applied sequence. For properly working devices the finite volume analysis showed only tolerable heating during MRI investigations in most cases. Only resonators transforming a few hundred mW into heat may reach temperature increases over 5 K. This requires resonators with volumes of several ten cubic centimeters, short inductor circuit paths with only a few 10 cm and a quality factor above ten. Using MR sequences, for which the MRI system manufacturer declares the highest specific absorption rate of 4 W/kg, vascular implants with a realistic construction, size and quality factor do not show temperature increases over a critical value of 5 K.

Conclusion

The results show dangerous heating for the assumed "worst-case scenario" only for constructions not acceptable for vascular implants. Realistic devices are safe with respect to temperature increases. However, this investigation discusses only properly working devices. Ruptures or partial ruptures of the wires carrying the electric current of the resonance circuits or other defects can set up a power source inside an extremely small volume. The temperature maps around such possible "hot spots" should be analyzed in an additional investigation.

Comparison of synchrotron radiation angiography with conventional angiography for the diagnosis of in-stent restenosis after percutaneous transluminal coronary angioplasty

AIMS

Synchrotron radiation angiography (SRA) is a novel tool for minimally invasive coronary artery imaging. The method uses subtraction of two images produced at energies bracketing the iodine K-edge after intravenous infusion of iodinated contrast agent. We investigated the accuracy of SRA for detecting in-stent restenosis (ISR).

METHODS AND RESULTS

We recruited 57 men, 4-6 months after successful PTCA. We visualized the right coronary artery (RCA) in 27 patients with 36 stented segments [12 segments with ISR>50% by quantitative coronary angiography (QCA)], and the left anterior descending artery (LAD) in 30 patients with 37 stented segments (10 ISR). SRA and QCA were performed within 2 days of each other. Two experienced observers unaware of QCA data evaluated the SRA results. Image quality was good or excellent in most patients. Global sensitivity was 64%, specificity was 95%, and positive and negative predictive values were approximately 85%. Inter-observer kappa concordance coefficient was 0.86. False negatives involved short eccentric lesions and superimposed segments, most frequently of the LAD. False positives occurred in intermediate stenoses slightly overestimated by SRA.

CONCLUSION

In men, this minimally invasive approach, using small radiation doses, detects significant ISR in the RCA, but the LAD poses difficulties because of superimposition with others structures.

Artifact-free coronary magnetic resonance angiography and coronary vessel wall imaging in the presence of a new, metallic, coronary magnetic resonance imaging stent

BACKGROUND

Coronary in-stent restenosis cannot be directly assessed by magnetic resonance angiography (MRA) because of the local signal void of currently used stainless steel stents. The aim of this study was to investigate the potential of a new, dedicated, coronary MR imaging (MRI) stent for artifact-free, coronary MRA and in-stent lumen and vessel wall visualization.

METHODS AND RESULTS

Fifteen prototype stents were deployed in coronary arteries of 15 healthy swine and investigated with a double-oblique, navigator-gated, free-breathing, T2-prepared, 3D cartesian gradient-echo sequence; a T2-prepared, 3D spiral gradient-echo sequence; and a T2-prepared, 3D steady-state, free-precession coronary MRA sequence. Furthermore, black-blood vessel wall imaging by a dual-inversion-recovery, turbo spin-echo sequence was performed. Artifacts of the stented vessel segment and signal intensities of the coronary vessel lumen inside and outside the stent were assessed. With all investigated sequences, the vessel lumen and wall could be visualized without artifacts, including the stented vessel segment. No signal intensity alterations inside the stent when compared with the vessel lumen outside the stent were found.

CONCLUSIONS

The new, coronary MRI stent allows for completely artifact-free coronary MRA and vessel wall imaging.

Contrast-Enhanced MR Angiography at 1.5 T After Implantation of Platinum Stents: In Vitro and In Vivo Comparison with Conventional Stent Designs

OBJECTIVE

The objective of our study was to evaluate the in vitro and in vivo 3D contrast-enhanced MR angiography characteristics of a new platinum-based balloon-expandable stent system and compare this system with a variety of competing metallic stents.

MATERIALS AND METHODS

All experiments were performed on 1.5-T scanners. In vitro experiments were performed using 10 stents implanted into a custom-built phantom. Different orientations of the stents along the magnetic field and multiple flip angles were examined. In addition, 19 patients underwent contrast-enhanced MR angiography after the implantation of 36 stents, including four patients with six platinum stents. Angiographic correlation was available for all 19 patients, and luminal patency and stent-induced artifacts were assessed quantitatively.

RESULTS

Of the tested balloon-expandable stents, only the platinum-based stents created artifact causing luminal narrowing of 30% or less. All other balloon-expandable stents induced larger artifacts that resulted in higher degrees of narrowing. Thus, if patent, the platinum-based stents allow significant in-stent stenosis to be ruled out reliably. Selected nitinol- or tantalum-based self-expandable stents also are suitable in this regard.

CONCLUSION

Of the tested devices, platinum-based stents are the only type of currently available balloon-expandable stent that creates 30% or less artifact-induced apparent stenosis and thus are suitable for MR angiography.

On the heating of inductively coupled resonators (stents) during MRI examinations

Stents that have been implanted to preserve the results of vascular dilatation are frequently affected by in-stent restenosis, which ideally should be followed up by a noninvasive diagnostic modality. Active MRI stents can enable this kind of follow-up, while normal metallic stents can not. The prototype stents investigated in this study were designed as electric resonating circuits without a direct connection to the MR imager, and function as inductively coupled transmit coils. The model of a long solenoid coil is used to describe the additional power loss caused by such resonators. The theoretically estimated temperature increase is verified by measurements for different resonators and discussed for worst-case conditions. The RF power absorption of an active resonator is negligible compared to the total power absorbed during MRI. The local temperature increase observed for prototypes embedded in phantoms is in a range that excludes direct tissue damage. However, ruptures in the conducting structure of a resonator can cause hot spots, which may establish a high local temperature. This hazard can be reduced by designing resonators with a low quality (Q) factor or by setting the circuit slightly off resonance; however, this would lower the nominal amplification for which the resonator was designed.

New metallic MR stents for artifact-free coronary MR angiography: feasibility study in a swine model

RATIONALE AND OBJECTIVES

The objective of this study was to investigate the potential for artifact-free coronary magnetic resonance angiography (cMRA) in the presence of dedicated metallic MR stents in vitro and in a swine model.

METHODS

All investigations were performed at 1.5 T, applying a standard cMRA gradient echo sequence with a T2 preparation pulse. Two prototypes of each hand-woven, mechanically woven, and lasered Aachen Resonance Coronary MR Stents made out of an MR-compatible metallic alloy and dilated to 2.5 mm and 4 mm were examined in a water bath.

RESULTS

Artifact behavior was judged independently by 2 radiologists as showing "no artifacts" for all tested stent types. Signal-to-noise ratios inside and outside of the stents were measured yielding a Pearson correlation coefficient of 0.98 (y = 1.22 + 0.92x). Nineteen stents (8 hand woven, 3 mechanically woven, 8 lasered) were deployed in coronary arteries of 19 domestic pigs and were examined by cMRA. Artifact behavior of the stents was analyzed by measuring the signal-to-noise ratio at the stent positions and compared with signal-to-noise ratio measurements outside of the stents, yielding a Pearson correlation coefficient of 0.90 (y = -0.75 + 1.06x).

CONCLUSIONS

All 3 prototypes of coronary MR stents allowed complete visualization of the stent lumen and consequently determination of stent patency by cMRA.

3.0 Tesla Magnetic Resonance Angiography of Endovascular Aortic Stent Grafts

RATIONALE AND OBJECTIVES

This study evaluated different stent grafts by 3 T magnetic resonance angiography (MRA) with respect to lumen visibility, susceptibility-induced signal loss, and type of stent artifacts compared with 1.5 T MRA in a phantom model.

METHODS

Six different stent-grafts (tube: n = 3, bifurcated: n = 3) were evaluated by 3 T and 1.5 T MRA using a tube phantom. MRA was performed using T1-weighted sequences at both systems with comparable parameters (3T: TR 5.4/TE 2.0/FA 30 degrees, 1.5 T: TR 6.2/TE 2.2/FA 30 degrees). A blind study of the image quality, including artifacts, was performed by 3 radiologists. Furthermore, signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) values were calculated. Statistical analysis was performed with Student's t test (P < 0.05).

RESULTS

One Elgiloy stent graft showed almost a complete intraluminal signal loss at 1.5 and 3 T. All other models could be evaluated by both systems by MRA, resulting in a favorable lumen visibility (score: 1) for prostheses made of nitinol. Scores for overall image quality and artifacts were the same for both MR systems. SNR and CNR values of the stented part of the vessel phantom increased from 320 +/- 33 to 618 +/- 40 and from 306 +/- 34 to 596 +/- 40 at 3 T when compared with 1.5 T, resulting in a significant signal gain of 93% at the higher field strength.

CONCLUSIONS

3 Tesla MRA of aortic stent grafts in a phantom model demonstrates an increase in SNR and CNR when compared with 1.5 T. However, the magnitude of imaging artifacts as well as coherent intraluminal signal loss within the stent does not increase equally in both MR systems.

CT and MR Imaging of Nitinol Stents with Radiopaque Distal Markers

PURPOSE

To evaluate imaging characteristics and artifacts of a nitinol stent with distal tantalum markers with computed tomography (CT) angiography and magnetic resonance (MR) angiography.

MATERIALS AND METHODS

A vascular phantom was built to simulate in-stent restenosis. A nitinol stent with tantalum markers (Luminexx stent) was evaluated with CT angiography in different orientations relative to the z-axis and with MR angiography in different positions relative to both B0 and the readout gradient. Stenosis measurements were compared with conventional digital subtraction angiography for both modalities. In-stent signal intensity obtained with different flip angles was assessed in two nitinol stents with distal markers (Luminexx stent and SMART stent) and one without markers (Memotherm-FLEXX stent).

RESULTS

Stenosis detection was not possible with CT angiography when the stent was perpendicular to the z-axis because of streak-like artifacts induced by tantalum markers. Stenosis evaluation with multiplanar reformation was accurate when the stent was in parallel and oblique orientations relative to the table axis. With MR angiography, metallic artifacts were mostly related to the stent orientation with B0, whereas orientation of the readout gradient had little influence. The mean error (overestimation) for stenosis measurements varied between 0.1% and 7.4% for CT imaging in parallel and oblique positions and 3.6% and 9.5% for MR imaging. Higher flip angles did not improve signal intensity inside the three stents tested.

CONCLUSION

CT and MR angiography can be used for evaluating the patency of stents with distal markers that are parallel or oblique relative to the table axis (iliac, carotid, or femoral stents). MR angiography is preferred if the stent is perpendicular to the table axis (renal stent).

Artifacts of vena cava filters ex vivo on MR angiography

We evaluated magnetic susceptibility artifacts of nine types of vena cava filters in MR angiography (MRA) at 1.0T ex vivo in order to assess the filters' compatibility with MRA. Each filter (tulip filter, tulip MReye filter, stainless Greenfield filter, titanium Greenfield filter, TrapEase filter, Simon filter, LGM Vena-Tech filter, Antheor temporary filter, and Bird's nest filter) was inserted into an acrylic tube (20 or 25 mm in diameter, 15 or 30 cm in length). Gd-DTPA was poured into each tube at a concentration of 1/500 and each was placed in a water-filled container for imaging. We evaluated artifacts of the filters according to the following criteria: signal void beyond the tube, 3+; signal void within the tube but at more than one-half the diameter of the tube, 2+; and signal void within the tube but at less than one-half the diameter of the tube, 1+. We evaluated artifacts originating at the tip, intermediate portion, and distal end of the filters. We judged the artifacts as follows: tulip (3+, 3+, 3+); tulip MReye (2+, 1+, 1+); stainless Greenfield (2+, 1+, 2+); titanium Greenfield (1+, 1+, 1+); TrapEase (1+, 2+, 1+); Simon (2+, 2+, 1+); LGM (2+, 2+, 1+); Antheor (2+, 2+, 2+); and Bird's nest (3+, 3+, 3+). The numbers in parentheses refer to the degree of signal void at the tip, intermediate portion, and distal end of the filter, respectively. The tulip filter and Bird's nest filter made of 304 stainless steel caused extensive signal voids beyond the areas defined by the filters. The signal voids in the remaining seven filters were limited to within the tube. We concluded that seven of the nine filters were compatible with MRA ex vivo.

Metallic renal artery MR imaging stent: artifact-free lumen visualization with projection and standard renal MR angiography

A cardiac-triggered free-breathing three-dimensional (3D) balanced fast field-echo projection renal magnetic resonance (MR) angiographic sequence was investigated for in-stent lumen visualization of a dedicated metallic renal artery stent. Fourteen prototype stents were deployed in the renal arteries of six pigs (in two pigs, three stents were deployed). Projection renal MR angiography was compared with standard contrast material-enhanced 3D breath-hold MR angiography. Artifact-free in-stent lumen visualization was achieved with both projection MR angiography and contrast-enhanced MR angiography. These promising results warrant further studies for visualization of in-stent restenosis.

Quantitative evaluation of susceptibility and shielding effects of nitinol, platinum, cobalt-alloy, and stainless steel stents

The purpose of this study is to quantitatively estimate the shielding and susceptibility effects of commonly used metallic stents on MR signal. Two experiments were performed using a 3D gradient echo sequence with short TE to image a stent phantom: 1) short TR and high flip angle (contrast enhanced MRA parameters), and 2) long TR (TR >> T(1)) and low flip angle. The factor characterizing susceptibility effects was estimated from the signal phase of the first experiment, and then the factor characterizing the shielding effects was derived from the second experiment. Susceptibility induced signal loss was negligible (<1%) for nonstainless-steel (nitinol, platinum, and cobalt-alloy) stents and totally destructive (100%) for the stainless steel stent. Signal loss due to RF shielding was 31-62% for nitinol stents, 14-50% for platinum stents, 50-77% for the cobalt-alloy stents (undetermined for the stainless steel stent), varied with stent orientation, diameter, and wall geometry. In summary, stents made of nitinol, platinum, and cobalt-alloy have negligible susceptibility effects but stents made of stainless steel may have complete dephasing. All stents have substantial shielding effects, which vary with composition, geometry, and orientation. Large platinum stents may have the smallest artifacts and are the best suited for postinterventional MR imaging.

A vascular stent as an active component for locally enhanced magnetic resonance imaging: initial in vivo imaging results after catheter-guided placement in rabbits

RATIONALE AND OBJECTIVE

A vascular stent constructed as a high frequency resonator improves the local signal-to-noise ratio at magnetic resonance (MR) imaging. After catheter placement and intravascular expansion, the stent can be used as an inductively coupled coil for MRI. The imaging properties of this balloon-expandable active MRI stent (AMRIS) were evaluated after x-ray fluoroscopy guided placement in the abdominal aorta of five rabbits using MR angiography (MRA) and flow measurements.

METHODS

The AMRIS was implanted in the abdominal aorta of five rabbits using a balloon catheter inserted through the common carotid artery. The rabbits were examined by MRA (3D fast low-angle shot) at 1.5 tesla before and after intravenous injection of an iron-oxide-based blood pool contrast medium (dose 50 micro mol Fe/kg) and flow measurements (ECG-triggered phase contrast cine gradient-echo sequence). Signal-to-noise ratios (SNR) were calculated and flow volume curves were generated. The in-stent increase in temperature was measured in vitro using a fiberoptic thermometry system.

RESULTS

The SNR was 5.0 +/- 0.6 outside the stent and 23.2 +/- 14.1 within the stent ( < 0.0 5) in plain MRA, 19.5 +/- 5.0 outside and 30.7 +/- 8.2 within the stent ( < 0.05) in contrast enhanced MRA, and 5.8 +/- 1.6 and 13.9 +/- 5.9, respectively ( < 0.05) in the magnitude images of the flow measurements. Flow volume curves within and distal to the stent were comparable.

CONCLUSIONS

The expandable active MRI stent produces local signal enhancement in MRA and MR flow measurements after catheter placement and thus may improve assessment of the stented vessel segment by MR imaging.

Selection of stents for treating iliac arterial occlusive disease

Intravascular stents play an increasingly important role in the treatment of iliac artery occlusive disease and their use has expanded the indications for percutaneous endoluminal therapies. The past several years have seen a sharp increase in the number of commercially available covered and uncovered stents. Knowledge of their design and mechanical properties is crucial for selecting the appropriate stent for a particular type of lesion. In this article, the indications for and results of iliac artery stent placement are reviewed and the various characteristics of the currently available stents that may influence operator choice for use in specific lesions are discussed.

MR-velocity mapping in vascular stents to assess peak systolic velocity. In vitro comparison of various stent designs made of Stainless Steel and Nitinol

INTRODUCTION

Peak systolic velocity (PSV) measurements of blood flow inside vascular stents allow reliable detection of in-stent re-stenosis. The purpose of this in vitro study was to evaluate the feasibility of obtaining PSV measurements inside vascular stents made of Stainless Steel and Nitinol, using a velocity encoded MR technique.

MATERIALS/METHODS

In a flow phantom, stents of Stainless Steel and Nitinol were studied. The phantom was integrated into a closed-tubing circuit driven by a MR dedicated pulsatile flow pump. MR imaging was performed on a 1.5 T system. The PSV in the tube without stent was used as the gold standard to determine the accuracy and the variability (paired t-test and Pittman's test) of the PSV measurements inside the stents.

RESULTS

PSV values inside the stents showed percentual difference in mean of -15 to 21% (P < 0.05) at a pump setting of 10 and 20 ml/s.

CONCLUSION

PSV measurements can be accurately obtained inside stents made of Stainless Steel and Nitinol. MR-velocity measurements may be used in patients to non-invasively evaluate stent patency and in-stent re-stenosis.

Stent struts and articulations: their impact on balloon-expandable stents' hoop strength, pushability, and radiopacity in an experimental setting

OBJECTIVES AND RATIONALE

To evaluate the hoop strength, the pushability, and the radiopacity of endovascular stents depending on their design.

MATERIAL AND METHODS

The Palmaz Medium (rectangular stent struts, no articulation = RE-NA), the Palmaz-Schatz Long-Medium (rectangular stent struts, central articulations = RE-CA), and the 39 mm and 29 mm version of the Palmaz Corinthian Stent (arch-like stent struts, omega hinges = AR-OH 1 and AR-OH 2) were included in the study. Hoop strength, pushability, and radiopacity were assessed in-vitro. A radiopacity score (RS)-ranging from 0 = invisible, 1 = poor, 2 = average, 3 = good, and 4 = very good-was used.

RESULTS

Mass adjusted hoop strength was nearly the same for the AR-OH 1 and the AR-OH 2 (AR-OH 1: 159.2 N/g*cm; AR-OH 2: 156.5 N/g*cm). Their hoop strengths per unit mass significantly exceeded that of a RE-NA (125 N/g*cm) and that of a RE-CA (75.3 N/g*cm). The most pushable stent was the AR-OH 2 (0.54 1/N) followed by the AR-OH 1 (0.47 1/N) and the RE-CA (0.169 1/N). Because of multiple stent dislocations, the RE-NA was considered nonflexible. At spotfilm mode the RE-NA was the most visible stent (RS 3.5) followed by the AR-OH 1 (RS 3.25), the RE-CA (RS 3.12), and the AR-OH 2 (RS 1.9). At continuous fluoroscopy the AR-OH 1 (RS 1.8) was better than the RE-CA (RS 1.125), the RE-NA (RS 1.0), and the AR-OH 2 (RS 0.6). At 7.5 pulses per second the RE-NA (RS 1.3) performed slightly better than the AR-OH 1 (RS 1.25), and clearly better than the RE-CA (RS 0.8), and the AR-OH 2 (RS 0.3).

CONCLUSION

Overall, the ideal stent-having high hoop strength, a low profile, a good pushability, and a good radiopacity-still does not exist. However, by changing strut design (from rectangular to arch-like struts) and by inserting articulations, hoop strength and pushability can be improved without reducing radiopacity.

Antiproliferative effects of the antiallergic agent azelastine on human aortic smooth-muscle cells: an in vitro study

RATIONALE AND OBJECTIVES

The aim of the study was to examine the effects of azelastine on proliferation, clonogenic activity, cell-cycle, and migration of human aortic smooth-muscle cells (haSMCs) in vitro.

METHODS

HaSMCs were treated for 4 days with azelastine (1 micromol/L, 25 micromol/L, 50 micromol/L). Half of the treated groups were incubated again with azelastine, the other half received azelastine-free medium every 4 days until day 20. The growth kinetics and clonogenic activity were assessed. The cell-cycle distribution was investigated by FACS -- analysis and the migratory ability was evaluated.

RESULTS

Azelastine inhibited the proliferation and the clonogenic activity of haSMCs in a dose dependent manner. A G2/M-phase block was induced and the migratory ability was significantly impaired.

CONCLUSION

Azelastine has the potential to inhibit the proliferation of haSMCs. If a sufficient dose can be applied either systemically or locally it could be a valuable substance to prevent restenosis.

Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent-graft

PURPOSE

To assess immediate and long-term outcome after femoropopliteal implantation of a Dacron-covered stent-graft in patients with peripheral arterial disease.

MATERIALS AND METHODS

This prospective cohort study included 30 consecutive patients who underwent Dacron-covered stent-graft implantation because of recurrent stenosis after percutaneous transluminal angioplasty in the femoropopliteal segment. After interventional treatment, 100 mg of acetylsalicylic acid daily and oral anticoagulation therapy (therapeutic level, international normalized ratio, 2.0-3.0) were administered. Patients were followed up with ankle-brachial index measurement, color-coded duplex ultrasonography, and angiography. Primary and secondary patency rates and postintervention complications were documented as was initial technical success. Kaplan-Meier and life table analyses were used for calculation of patency rates.

RESULTS

Initial technical success was achieved in all 30 patients, with significant improvement of ankle-brachial index from a preintervention mean of 0.5 +/- 0.14 (SD) to a postintervention mean of 0.8 +/- 0.17 (P <.001). Postimplantation noninfectious fever and leukocyte and C-reactive protein level elevation occurred in 12 patients (40%), and 17 patients (57%) reported persistent pain at the site of implantation for a mean of 5 days (range, 2-28 days). Early recurrent occlusion within the first 24 hours was found in five patients (17%). Within the mean follow-up period of 60 months +/- 10, restenosis occurred in 25 patients (83%). At 6, 12, 36, and 72 months, respectively, primary patency rates were 27%, 23%, 17%, 17%, and secondary patency rates were 63%, 60%, 34%, 34%.

CONCLUSION

Implantation of Dacron-covered stent-grafts for treatment of femoropopliteal lesions leads to high early and late restenosis rates, with a considerable rate of complications, such as fever and pain.

Artifact-free in-stent lumen visualization by standard magnetic resonance angiography using a new metallic magnetic resonance imaging stent

BACKGROUND

Metallic stents cause susceptibility and radiofrequency artifacts on MR images, which, up to now, have not allowed for complete visualization of the stent lumen by MR angiography. The aim of this study was to investigate the potential of a new dedicated renal MRI stent for artifact-free in-stent lumen visualization in vitro and in a swine model.

METHODS AND RESULTS

In vitro investigations were performed with prototypes of balloon-expandable Aachen Resonance Renal MRI Stents dilated to diameters of 3 to 6 mm and placed in an aqueous gadolinium solution (1:25). Phase-contrast and contrast-enhanced T1-weighted gradient echo images were acquired. Renal MRI stents (n=12) were deployed in the renal arteries of 6 pigs. Renal arteries were examined with phase-contrast angiography and with flow measurements before and after stent placement in the stented area, respectively. Additionally, a contrast-enhanced, T1-weighted, spoiled-gradient echo sequence after administration of 0.2 mmol gadolinium-DTPA/kg body weight was performed after stent placement. The visibility of artifacts was analyzed on in vitro and in vivo images by two investigators who knew the stent positions. Stent positions were determined visually (in vitro) or by x-ray angiography (animal experiments). No artifacts were detected independent of the applied imaging sequence and the stent orientation to the main magnetic field.

CONCLUSION

The examined prototypes of fully MR-compatible MRI stents allow artifact-free visualization of the stent lumen with phase-contrast and contrast-enhanced T1-weighted angiography, as well as phase-contrast flow measurements in the stented area.

Improved in-stent magnetic resonance angiography with high flip angle excitation

RATIONALE AND OBJECTIVES

To optimize the intraluminal signal intensity of a nitinol stent by performing contrast-enhanced three-dimensional magnetic resonance angiography (CE-MRA) with varying flip angles (FAs).

METHODS

Contrast-enhanced magnetic resonance angiography at 1.5 T and FAs of 30 degrees, 100 degrees, and 150 degrees was performed on five sheep with 10 iliac nitinol stents (Memotherm-FLEXX). Maximum-intensity projections (MIPs) and composite images of MIPs were performed and compared.

RESULTS

Reconstructed MIPs at an FA of 150 degrees showed a slightly disturbed lumen visibility inside the stent accompanied by low-grade lumen visibility outside the stent and vice versa for an FA of 30 degrees. Composite images of a 30 degrees MIP added to a 150 degrees MIP resulted in improved image quality compared with the standard MIP of a single FA.

CONCLUSIONS

Signal loss due to radiofrequency shielding inside nitinol stents imaged by CE-MRA can be reduced by applying high FAs. Composite MIP images allow simultaneous visualization of the lumen inside as well as outside the stent.

The active magnetic resonance imaging stent (AMRIS): initial experimental in vivo results with locally amplified MR angiography and flow measurements

RATIONALE AND OBJECTIVES

Magnetic resonance (MR) is limited by artifacts in vessels after stenting. An active MR imaging stent (AMRIS) allows for artifact-free imaging with local improvement in signal-to-noise ratio (SNR). In a rabbit model, we evaluated the imaging properties by MR angiography (MRA) and flow measurements.

METHODS

The AMRIS was placed in the abdominal aorta of five rabbits. At 1.5 T, MRA (three-dimensional fast low-angle shot) was performed before and after intravenous injection of an iron oxide-based, blood-pool contrast medium (dose, 50 micromol Fe/kg), and flow measurements were performed (electrocardiographically triggered phase-contrast cine gradient-echo sequence). Mean SNRs were calculated and flow volume curves were generated.

RESULTS

The SNR was 6.0 +/- 0.6 (outside the stent) versus 12.3 +/- 1.1 (inside the stent, P < 0.05) for plain MRA, 21.2 +/- 0.6 versus 40.6 +/- 5.2 (P < 0.05) for contrast-enhanced MRA, and 5.4 +/- 0.4 versus 13.7 +/- 2.1 (P < 0.05) for the magnitude images of flow measurements. Flow volume curves within and distal to the stent were comparable.

CONCLUSIONS

By using the AMRIS as a vascular stent, the stented vessel segment can be examined with enhanced signal intensity on MRI.